Quality of life in patients with larygeal/hypopharyngeal cancer following total/partial laryngectomy.

AIM: To estimate the quality of life (QOL) of patients with carcinoma of larynx/hypopharynx using the EORTC QLQ-C30 and QLQ-H and N35 questionnaires in relation to the reference values (RV), total (TL) / partial (PL) laryngectomy/ pharyngectomy, combined treatment (surgery, radiotherapy, chemotherapy) (CT) and the time elapsed since surgery.

METHODS

The questionnaires were answered by 45 patients in the first 6 months of 2011. Sixteen (35.6%) patients had PL and 29 (64.4%) TL. Postoperatively, CT was performed in 34 (75.6%) patients (group A), and 11 (24.4%) patients (group B) only had surgery. The time elapsed from surgery of ≤12 months was found in 11 (24.4%) patients in the group A1, and 34 (75.6%) of more than 12 months in the group B1. Comparison was made between all scales of the questionnaires, global (GS), functional (FS) and general symptomatic (GSS) QLQ-C30 and specific symptomatic scale (SSS) QLQ-H and N35.

RESULTS

Comparing our results from all scales of both questionnaires with RV there was no statistically significant differences, except for SSS relating to speech problems (p=0.052574). Comparing PL and TL there was a decrease in FS (p=0.025517) and increased problems with speech, swallowing, sensation, coughing and social contact in SSS (p=0.017595) in TL. Comparing A and B groups, there was a decrease in FS (p=0.00531) increase of all symptoms in GSS (p=0.043388) and SSS (p=0.0505385) in the A group. Comparing A1 and B1 groups better FS (p=0.042271) was registered in A1.

CONCLUSION

Quality of life of our patients is not significantly different from the QOL of similar patients in the world. Comparing all groups, QLQ-C30 and QLQ-H and N35 showed us clear differences in QOL and their clinical use is justified.